EP3744714
(2S)-N-[(1S)-1-sýanó-2-fenýletýl]-1,4-oxasepan-2-karboxamíð sem dípeptidýl peptíðasa I hindrar
:
EP einkaleyfi í gildi á Íslandi:
23.1.2015:
15.1.2025:
20173862.2
:
19.3.2025:
15.4.2025
:
22.1.2035:
22.1.2026:
31.1.2026
:
(2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE I INHIBITORS
23.1.2015
15.1.2025
19.3.2025
15.4.2025
22.1.2026
:
Astrazeneca AB:
151 85 Södertälje, SE
:
LÖNN, Hans, Roland:
Macclesfield Cheshire SK10 4TG, GB
:
CONNOLLY, Stephen:
Macclesfield Cheshire SK10 4TG, GB
:
SWALLOW, Steven:
Macclesfield Cheshire SK10 4TG, GB
:
KARLSSON, Staffan PO:
431 83 Mölndal, SE
:
AURELL, Carl-Johan:
431 83 Mölndal, SE
:
PONTÉN, John Fritiof:
Macclesfield Cheshire SK10 4TG, GB
:
DOYLE, Kevin, James:
Cambridge CB21 6GH, GB
:
VAN DE POËL, Amanda Jane:
Saffron Walden Essex CB10 1XL, GB
:
JONES, Graham Peter:
Cambridge CB21 6GH, GB
:
WATSON, David Wyn:
Cambridge CB21 6GH, GB
:
MACRITCHIE, Jaqueline Anne:
Saffron Walden Essex CB10 1XL, GB
:
PALMER, Nicholas John:
Macclesfield Cheshire SK10 4TG, GB
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201461931090 P:
24.1.2014:
US
:
C07D 267/10, C07D 413/14, C07D 413/12, C07D 417/12, A61K 31/553, A61P 11/00
: 11
: 14.3.2025
: 22.1.2026
: Árnason Faktor ehf.